Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
Pancreatic cancer (PC) is an aggressive cancer subtype presenting unmet clinical challenges. Conventional chemotherapy, which includes antimetabolite gemcitabine (GEM), is seriously undermined by a short half-life, its lack of targeting ability, and systemic toxicity. GEM incorporation in self-assem...
Saved in:
Main Authors: | Miguel Pereira-Silva (Author), Darío Miranda-Pastoriza (Author), Luis Diaz-Gomez (Author), Eddy Sotelo (Author), Ana Cláudia Paiva-Santos (Author), Francisco Veiga (Author), Angel Concheiro (Author), Carmen Alvarez-Lorenzo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
by: Qiwei Wu, et al.
Published: (2022) -
Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
by: Zhang R, et al.
Published: (2017) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine-Feasibility of Orally Administrable Nucleoside Analogs
by: Yasuhiro Tsume, et al.
Published: (2014) -
Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
by: Immacolata Maietta, et al.
Published: (2022) -
New Advances in Biomedical Application of Polymeric Micelles
by: Ana Figueiras, et al.
Published: (2022)